Sun Pharmaceutical Industries Ltd. | SUNPHARMA | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2019
2020
2021
2022
2023
Revenue
Revenue
290,659328,375334,981386,545438,857
Cost of revenue
Cost of revenue
-78,690-92,305-86,901-103,515-106,622
Gross Profit
Gross Profit
211,969
236,071
248,081
283,030
332,235
Sales, general & ad...
Sales, general and administrative
-148,894-166,329-163,403-180,592-214,506
Depreciation
Depreciation and amortization
-17,533-20,528-20,800-21,437-25,294
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
015601,540-1,261
Operating income
Operating income EBIT
45,543
49,370
63,878
82,540
91,174
 
      
Profit before tax
Profit before tax
38,10250,09627,75744,81394,084
Net Income
Net income
26,654
37,649
28,802
32,727
84,736
 
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
11.11
15.69
12.00
13.60
35.30